Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment?

Viral Infections, Non-HIV

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review

Ann Intern Med.

Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM

doi: 10.7326/M20-2496.

Viral Infections, Non-HIV

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Int J Rheum Dis.

Shah S, Das S, Jain A, Misra DP, Negi VS

doi: 10.1111/1756-185X.13842.

Viral Infections, Non-HIV

Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review

J Toxicol Environ Health B Crit Rev.

Pereira BB

doi: 10.1080/10937404.2020.1752340.

Viral Infections, Non-HIV

Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings

doi: 10.1016/j.ijsu.2020.05.018.

Viral Infections, Non-HIV

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Lancet.

Mehra MR, Desai SS, Ruschitzka F, Patel AN

doi: 10.1016/S0140-6736(20)31180-6.

HIV / AIDSViral Infections, Non-HIV

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

HIV Med.

Cooper TJ, Woodward BL, Alom S, Harky A

doi: 10.1111/hiv.12911.

Viral Infections, Non-HIV

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19

Asia Pac J Ophthalmol (Phila).

Ruamviboonsuk P, Lai TYY, Chang A, Lai CC, Mieler WF, Lam DSC, for Asia-Pacific Vitreo-Retina Society.

doi: 10.1097/APO.0000000000000289.

Viral Infections, Non-HIV

Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis

Br J Haematol.

Xiong M, Liang X, Wei YD

doi: 10.1111/bjh.16725.

Viral Infections, Non-HIV

Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients

doi: 10.1002/jmv.26023.

Related content

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review

Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19

Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis

Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients